GGrantIndex
← Search

A PHASE I, OPEN LABEL, STUDY TO EVALUATE THE SAFETY AND IMMUNE FUNCTION EFFEC

$4,620M01FY2005RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →